Terms: = Pancreatic cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Staging
4 results:
1. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
[No Abstract] [Full Text] [Related]
2. Extent of Lymph Node Dissection for Accurate staging in Intrahepatic Cholangiocarcinoma.
Kim SH; Han DH; Choi GH; Choi JS; Kim KS
J Gastrointest Surg; 2022 Jan; 26(1):70-76. PubMed ID: 34100250
[TBL] [Abstract] [Full Text] [Related]
3. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].
Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y
Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035
[No Abstract] [Full Text] [Related]
4. [cancer screening with PET: advantages and limitations].
Kawada S; Suzuki Y; Hinohara S; Koide S; Ono Y; Ashikaga H
Rinsho Byori; 2007 Jul; 55(7):656-67. PubMed ID: 17718062
[TBL] [Abstract] [Full Text] [Related]
